1. Home
  2. PODD vs IBKR Comparison

PODD vs IBKR Comparison

Compare PODD & IBKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PODD
  • IBKR
  • Stock Information
  • Founded
  • PODD 2000
  • IBKR 1977
  • Country
  • PODD United States
  • IBKR United States
  • Employees
  • PODD N/A
  • IBKR N/A
  • Industry
  • PODD Medical/Dental Instruments
  • IBKR Investment Bankers/Brokers/Service
  • Sector
  • PODD Health Care
  • IBKR Finance
  • Exchange
  • PODD Nasdaq
  • IBKR Nasdaq
  • Market Cap
  • PODD 22.1B
  • IBKR 30.9B
  • IPO Year
  • PODD 2007
  • IBKR 2007
  • Fundamental
  • Price
  • PODD $319.08
  • IBKR $66.35
  • Analyst Decision
  • PODD Strong Buy
  • IBKR Strong Buy
  • Analyst Count
  • PODD 18
  • IBKR 7
  • Target Price
  • PODD $337.06
  • IBKR $65.93
  • AVG Volume (30 Days)
  • PODD 571.3K
  • IBKR 5.0M
  • Earning Date
  • PODD 11-06-2025
  • IBKR 10-16-2025
  • Dividend Yield
  • PODD N/A
  • IBKR 0.48%
  • EPS Growth
  • PODD N/A
  • IBKR 29.12
  • EPS
  • PODD 3.32
  • IBKR 2.07
  • Revenue
  • PODD $2,359,500,000.00
  • IBKR $5,948,000,000.00
  • Revenue This Year
  • PODD $29.18
  • IBKR $15.48
  • Revenue Next Year
  • PODD $18.16
  • IBKR $7.09
  • P/E Ratio
  • PODD $95.87
  • IBKR $31.96
  • Revenue Growth
  • PODD 26.00
  • IBKR 20.33
  • 52 Week Low
  • PODD $226.50
  • IBKR $32.82
  • 52 Week High
  • PODD $353.50
  • IBKR $73.35
  • Technical
  • Relative Strength Index (RSI)
  • PODD 49.89
  • IBKR 45.94
  • Support Level
  • PODD $312.05
  • IBKR $68.11
  • Resistance Level
  • PODD $322.58
  • IBKR $71.09
  • Average True Range (ATR)
  • PODD 9.00
  • IBKR 2.58
  • MACD
  • PODD 0.53
  • IBKR -0.27
  • Stochastic Oscillator
  • PODD 84.70
  • IBKR 14.08

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

About IBKR Interactive Brokers Group Inc.

Interactive Brokers is a large, automated, retail and institutional brokerage that boasted nearly $570 billion in customer equity at the end of 2024. The company cut its teeth as a market maker, introducing US financial markets to automated and algorithmic training before expanding into brokerage services in 1993. The firm has a wide-ranging client base, with its best-in-class order execution and extremely low margin lending rates catering to a sophisticated audience of hedge funds, proprietary traders, and introducing brokers that account for about 45% of the firm's commissions. With operations spanning more than 160 electronic exchanges, 36 countries, and 28 currencies, Interactive Brokers caters to a global clientele, with more than 80% of active accounts sitting outside the US.

Share on Social Networks: